Complex distribution for approved medicines
Inceptua has a very experienced commercialization team, with a patient centric approach. Our core competence is to successfully bring specialty, rare disease, and orphan drugs to the market. Our team puts equal focus on commercial, medical and market access, securing the holistic approach needed to succeed.
- Extensive launch experience
- Strong strategic and practical marketing and sales know-how
- Business intelligence, marketing planning and execution
-
Sales operations with highly scientific field managers and reps
- Flexibility to expand tailor-made sales forces around a product
- Global and regional medical planning and execution
- Scientific development of the field
- Field medical affairs management
- Key Opinion Leader network management
- National, regional and local pricing and patient access operations
- Global price and launch sequence strategy analysis and execution
- Health outcomes and value
Inceptua in-license or partner late stage assets or commercial stage products. Our partnership models are flexible and the structure depends on the strategic objectives of our partners.
Licensed Distribution
Once a medicine has marketing approval Inceptua can provide specialty distribution of licensed products product in a defined territory. Using our high touch patient centric approach and supply chain expertise, Inceptua provides a “White Glove” distribution service, for complex specialty products.
Inceptua’s offering facilitates high supply control, to ensure patient safety and drug supply integrity. For some companies, setting up infrastructure in non-reach or non-focus regions can be very expensive if it is not already in place. Also, in some cases, pharmaceutical company supply chains are not optimized to support complex storage / distribution (cold chain, frozen, emergency use etc.) of individual packs.
Also, the typical pharmaceutical wholesaler generally is not set up to manage these lower volume highly specialised medicines. This offering allows pharma companies to utilize Inceptua’s specialized distribution network to support the distribution of their medicines, wherever it is needed.
- Global distribution experts of speciality licensed medicines
- Local expertise and global logistical knowhow, utilising Inceptua’s specialized distribution network to support requests for products
- Route to market without the need to set up own infrastructure
- “White Glove” service for complex supply situations requiring specialist warehousing, shipping and regulatory expertise
- Commercial and Medical expertise with Medical Information (MI) and Medical Science Liaisons (MSL) support
Jetrea® (ocriplasmin)
Jetrea is a truncated form of human plasmin and is a first-in-class pharmacological vitreolysis therapy approved to treat patients with symptomatic vitreomacular adhesion or vitreomacular traction.
Farydak® (panobinostat)
Farydak (panobinostat) is a prescription oral medication used in combination with proteasome inhibitors and corticosteroids to treat patients with relapsed or refractory multiple myeloma who have received prior treatments.
Apealea® (paclitaxel micellar)
Apealea (paclitaxel micellar) is a prescription medicine, indicated for the treatment of adult patients with first relapse of platinum-sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer, in combination with carboplatin
If you would like to speak to a medical representative, report a suspected adverse drug reaction or have a product quality complain please follow the link: Contacts
Inceptua Pharma is unable to provide advice on personal medical matters. Please consult your doctor or other relevant health professional for specific, health-related advice and support.
Our team is engaged, entrepreneurial, and patient centric, with a long track record bringing products to the market. With our significant experience of different partnership models, we are open for traditional in-licensing as well as flexible distribution set-ups. Our adaptable approach allows us to work with tailored partnership solutions that best support the needs of our partners and their mid- to long-term objectives.
Ask our experts
About
About
About
Early Access
Clinical Trial Supply
Inceptua Group company information, privacy policy, impressum and more.
0157_NPM_11/22
November 2022